Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 9/20 | 0.70 |
| ▸ | ADORA2B | P29275 | 7/20 | 0.70 |
| ▸ | ADORA3 | P0DMS8 | 5/20 | 0.70 |
| ▸ | ADORA1 | P30542 | 5/20 | 0.70 |
| ▸ | TSHR | P16473 | 3/20 | 0.70 |
| ▸ | HSP90B1 | P14625 | 3/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.70 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.70 |
| ▸ | TMIGD3 | P0DMS9 | 1/20 | 0.70 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.70 |
| ▸ | MEN1 | O00255 | 1/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Neca SCHEMBL19928418 | 0.82 | TSHR (1.00) | ADORA2AADORA2BADORA3ADORA1TSHR | |
| Neca SCHEMBL30656108 | 0.82 | TSHR (1.00) | ADORA2AADORA2BADORA3ADORA1TSHR | |
| Neca SCHEMBL30036568 | 0.82 | TSHR (1.00) | ADORA2AADORA2BADORA3ADORA1TSHR | |
| Neca SCHEMBL19928417 | 0.82 | TSHR (1.00) | ADORA2AADORA2BADORA3ADORA1TSHR | |
| Neca SCHEMBL29361791 | 0.82 | TSHR (1.00) | ADORA2AADORA2BADORA3ADORA1TSHR | |
| Neca SCHEMBL18089301 | 0.82 | TSHR (1.00) | ADORA2AADORA2BADORA3ADORA1TSHR | |
| Neca SCHEMBL16585523 | 0.82 | TSHR (1.00) | ADORA2AADORA2BADORA3ADORA1TSHR | |
| Neca SCHEMBL12119012 | 0.82 | TSHR (1.00) | ADORA2AADORA2BADORA3ADORA1TSHR | |
| SCHEMBL13694990 | 0.80 | P2RX3 (0.67) | ADORA2AADORA2BADORA3ADORA1MAPK1 | |
| SCHEMBL15482193 | 0.80 | P2RX3 (0.67) | ADORA2AADORA2BADORA3ADORA1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119561228-A | New energy storage method, equipment and medium based on high-efficiency conversion technology | 国网江苏省电力有限公司盐城供电分公司 | 2025-03-04 | — | — | CN | claimed |
| EP-4426727-A2 | SPECIFIC CONJUGATION OF AN ANTIBODY | Hangzhou Dac Biotech Co., Ltd. (CN) | 2024-09-11 | — | — | EP | claimed |
| CN-114936745-B | Method and device for reducing carbon emission of electric power system based on carbon cost allocation | 国网浙江省电力有限公司经济技术研究院 | 2024-06-07 | — | — | CN | claimed |
| WO-2022078524-A4 | SPECIFIC CONJUGATION OF AN ANTIBODY | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2022-12-08 | — | — | WO | claimed |
| CN-114936745-A | Method and device for reducing carbon emission of electric power system based on carbon cost apportionment | 国网浙江省电力有限公司经济技术研究院 | 2022-08-23 | — | — | CN | claimed |
| WO-2022078524-A2 | SPECIFIC CONJUGATION OF AN ANTIBODY | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2022-04-21 | — | — | WO | claimed |
| CN-113900465-B | Intelligent positioning visual dispensing system for precise products | 深圳市领志光机电自动化系统有限公司 | 2022-02-22 | — | — | CN | claimed |
| CN-112072703-B | Flexibility evaluation method and system suitable for new energy access planning | 华北电力大学 | 2022-02-08 | — | — | CN | claimed |
| US-20250390498-A1 | SYSTEM AND METHOD FOR ESTIMATING CONFIDENCE AND IMPLEMENTING METACOGNITIVE ABILITIES IN ARTIFICIAL INTELLIGENCE SYSTEMS | STANDARD CHARTERED BANK, SINGAPORE BRANCH (SG) | 2025-12-25 | — | — | US | disclosed |
| US-20250250358-A1 | DEGRADATION OF SURFACE PROTEINS USING DUAL BINDING AGENT | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-08-07 | — | — | US | disclosed |
| EP-4580673-A2 | BIEPITOPIC TETRAVALENT ANTIBODY TARGETING EGFR | SystImmune, Inc. (US) | 2025-07-09 | — | — | EP | disclosed |
| CN-118109509-B | Application of GhBCCP gene in regulating and controlling plant seed size | 安阳工学院 | 2025-04-01 | — | — | CN | disclosed |
| US-20250101098-A1 | ANTIBODIES AND ANTIBODY CONJUGATES SPECIFIC FOR NECTIN-4 AND METHODS OF USE THEREOF | ARES CAPITAL CORPORATION, AS COLLATERAL AGENT | 2025-03-27 | — | — | US | disclosed |
| CN-118006631-B | Application of GhBCCP gene in regulation and control of vegetable oil accumulation | 安阳工学院 | 2025-03-04 | — | — | CN | disclosed |
| WO-2022150787-A2 | VARIANT CH1 DOMAINS AND VARIANT CL DOMAINS ENGINEERED FOR PREFERENTIAL CHAIN PAIRING AND MULTI-SPECIFIC ANTIBODIES COMPRISING THE SAME | ADIMAB, LLC (US) | 2022-07-14 | — | — | WO | disclosed |
| WO-2022128950-A1 | PHOSGENE SYNTHESIS BY CONVERSION OF A GAS MIXTURE CONTAINING CHLORINE AND CARBON MONOXIDE ON AN ORGANIC CATALYST CONTAINING CHLORIDE ANIONS | COVESTRO DEUTSCHLAND AG (DE) | 2022-06-23 | — | — | WO | disclosed |
| US-20220169693-A1 | Screening Assays, Modulators and Modulation of Intracellular Signalling Mediated by Immunoglobulin Superfamily Cell Adhesion Molecules | THE UNIVERSITY OF WESTERN AUSTRALIA (AU) | 2022-06-02 | — | — | US | disclosed |
| US-11311575-B2 | Methods for engineering highly active T cell for immunotherapy | CELLECTIS (FR) | 2022-04-26 | — | — | US | disclosed |
| CN-113900465-B | Intelligent positioning visual dispensing system for precise products | 深圳市领志光机电自动化系统有限公司 | 2022-02-22 | — | — | CN | disclosed |
| CN-112072703-B | Flexibility evaluation method and system suitable for new energy access planning | 华北电力大学 | 2022-02-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250101098-A1 | ANTIBODIES AND ANTIBODY CONJUGATES SPECIFIC FOR NECTIN-4 AND METHODS OF USE THEREOF | NECTIN4, EPCAM, CD22 | ADORA2A 1305/4885ADORA2B 2193/4885ADORA3 1066/4885 |
| US-20220169693-A1 | Screening Assays, Modulators and Modulation of Intracellular Signalling Mediated by Immunoglobulin Superfamily Cell Adhesion Molecules | AGER, IGSF11, ICAM1 | ADORA2A 485/4885ADORA2B 1354/4885ADORA3 823/4885 |
| US-20250390498-A1 | SYSTEM AND METHOD FOR ESTIMATING CONFIDENCE AND IMPLEMENTING METACOGNITIVE ABILITIES IN ARTIFICIAL INTELLIGENCE SYSTEMS | RIMKLA, CHAT, LGALS4 | ADORA2A 2986/4885ADORA2B 4529/4885ADORA3 3710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.